Disclosure Plus

NanoTIM Co. Ltd. Decides to Invest 16.7 Billion Won in New Factory Construction

Park Sun-Yeop
2026-07-03 17:55:57
[Edaily Reporter Park Sun-Yeop ] NanoTIM Co. Ltd.(417010)announced on the 3rd that it has decided to invest in new facilities for urethane production and the research and manufacturing of fire extinguishing agents.
The investment amount is 16,703,160,000 won. This represents 34.67% of the company’s equity capital of 48,180,610,000 won.
The purpose of the investment is to construct a plant for urethane production and the research and manufacturing of fire extinguishing agents. The investment site is located at 403-1, Dungok-dong, Yuseong-gu, Daejeon.
The investment period runs from the 24th of last month through December 15, 2027.

Economy

Corporation

IT·Science

Economy

"Why Should I Buy That Apartment for You?"... Will It Take 30 Years for Gen Z and Millennials to Buy a Home in Seoul?

(Photo: Blind) One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
2026-10-04 12:00:03
Samsung to Break Ground This Month on Yongin National Semiconductor Industrial Complex… Unveils Blueprint to Local Residents
2026-10-04 06:00:03
"600 Billion Won from a Single Pixel Game"... The Next Move by a 13-Year-Old Game Developer [VC Cradle]
2026-10-03 16:06:03

Corporation

GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]

The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
2026-10-03 07:22:03
G.I. Innovation and G2G Rise 20% on Expectations of Technology Exports [Bio Spotlight]
2026-10-03 07:22:02
“AI Generates Candidate Compounds, PROTEINA CO., LTD. Validates Them”… Targeting the ‘Wet Lab’ Bottleneck in New Drug Development [Invest Bio]
2026-10-03 06:01:02

IT·Science

Jeong Sang-won, CEO of Embricks: “Realizing In-Body CAR-T”… The Secret to Weathering the Investment Slump

(Graphic: ChatGPT) “While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…
2026-10-04 07:32:02
A-Sleep Partners with Hyundai Engineering & Construction and Samsung Electronics on 'Sleep Orchestra'… "We Will Create a Wall Pad for the Bedroom"
2026-10-04 07:02:03
CEO Cha Sang-hoon, Who Stepped Down from Management: Will He Prove the Value of “SAFA” Through “APB-R3”? [Bio Industry Figures in the Spotlight]
2026-10-03 17:01:02